Skip to main content
Log in

Schwere Infektionen

Ursachen und Management von Sepsis

Severe infections

Causes and management of sepsis

Der Internist Aims and scope Submit manuscript

Zusammenfassung

Die klinische Definition der Sepsis ist noch jung, hat sich aber trotz der wenig spezifischen Definition rasch zu einem wichtigen Konzept entwickelt. Das bessere Verständnis der wichtigen Maßnahmen zur Vermeidung von Organdysfunktionen hat erheblich zur Verbesserung der Prognose von Sepsispatienten beigetragen, auch wenn sich spezifische Eingriffe in den Entzündungsprozess bisher nicht als wirksam erwiesen haben. Die klinischen Zeichen der Sepsis sind wesentliche Charakteristika von schweren Infektionen. Im vorliegenden Beitrag wird das allgemeine und spezifische Management schwerer Infektionen, denen Kriterien der Sepsis gemeinsam sind, vorgestellt.

Abstract

The sepsis syndrome has only recently been defined as a clinical syndrome but despite its unspecific definition it has evolved rapidly into an important concept. Although specific therapeutic interventions targeting the inflammatory pathway have not yet been effective in treating sepsis, a better understanding of mechanisms leading to organ dysfunction has led to better management of patients with sepsis. Clinical signs of systemic inflammatory response syndrome (SIRS) or sepsis are hallmarks for the definition of severe infections. Current guidelines are presented for the management of a number of severe infectious syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Alberti C, Brun-Buisson C, Goodman SV et al (2003) Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 168:77–84

    Article  PubMed  Google Scholar 

  2. Audebert FX, Hanses F, Schneidewind A et al (2007) Epidemiologie der schweren Sepsis in einem deutschen Universitätsklinikum. Med Klin (Munich) 102:195–202

    Google Scholar 

  3. Baddour LM, Wilson WR, Bayer AS et al (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111:e394–e434

    Article  PubMed  Google Scholar 

  4. Bauer MP, Kuijper EJ, Dissel JT van (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 15:1067–1079

    Article  PubMed  CAS  Google Scholar 

  5. Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655

    Article  PubMed  CAS  Google Scholar 

  6. Carpenter CR, Keim SM, Upadhye S et al (2009) Risk stratification of the potentially septic patient in the emergency department: the Mortality in the Emergency Department Sepsis (MEDS) score. J Emerg Med 37:319–327

    Google Scholar 

  7. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637

    Article  PubMed  Google Scholar 

  8. Deutsche Gesellschaft für Neurologie (2008) Bakterielle (eitrige) Meningoenzephalitis. In: Deutsche Gesellschaft für Neurologie (Hrsg) (2008) Leitlinien für Diagnostik und Therapie in der Neurologie

  9. Dusemund F, Bucher B, Meyer S et al (2013) Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance. Eur J Clin Microbiol Infect Dis 32:51–60

    Article  PubMed  CAS  Google Scholar 

  10. Engel C, Brunkhorst FM, Bone HG et al (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33:606–618

    Article  PubMed  Google Scholar 

  11. Gaieski DF, Mikkelsen ME, Band RA et al (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38:1045–1053

    Article  PubMed  Google Scholar 

  12. Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30:2369–2413

    Google Scholar 

  13. Hoffken G, Lorenz J, Kern W et al (2009) Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the Competence Network CAPNETZ Germany. Pneumologie 63:e1–e68

    Article  PubMed  CAS  Google Scholar 

  14. Kumar A, Haery C, Paladugu B et al (2006) The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. J Infect Dis 193:251–258

    Google Scholar 

  15. Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596

    Article  PubMed  Google Scholar 

  16. Kumar G, Kumar N, Taneja A et al (2011) Nationwide trends of severe sepsis in the 21st century (2000–2007). Chest 140:1223–1231

    Article  PubMed  Google Scholar 

  17. Lagu T, Rothberg MB, Shieh MS et al (2012) Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003–2007. Crit Care Med 40:754–761

    Article  PubMed  Google Scholar 

  18. Lee CC, Chen SY, Tsai CL et al (2008) Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock 29:322–327

    PubMed  Google Scholar 

  19. Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256

    Article  PubMed  Google Scholar 

  20. Rivers EP, Nguyen B, Havstad S et al (2001) Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377

    Google Scholar 

  21. Seymour CW, Rea TD, Kahn JM et al (2012) Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. Am J Respir Crit Care Med 186:1264–1271

    Article  PubMed  Google Scholar 

  22. Solomkin JS, Mazuski JE, Bradley JS et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50:133–164

    Article  PubMed  Google Scholar 

  23. Stevens DL, Bisno AL, Chambers HF et al (2005) Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41:1373–1406

    Article  PubMed  Google Scholar 

  24. Valles J, Palomar M, Alvarez-Lerma F et al (2013) Evolution over a 15-year period of clinical characteristics and outcomes of critically ill patients with community-acquired bacteremia. Crit Care Med 41:76–83

    Article  PubMed  Google Scholar 

  25. Weissinger F, Auner HW, Bertz H et al (2012) Infektiöse Komplikationen nach Hochdosistherapie und autologer Stammzelltransplantation. In: Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (Hrsg) Onkopedia Leitlinien, Berlin

  26. World Health Organisation (2010) Guidelines for the treatment of malaria. WHO, Geneva

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht. Es besteht für keines der aufgeführten Produkte (Arzneimittel, Diagnostika o. Ä.) für einen der beteiligten Autoren ein Interessenkonflikt.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Salzberger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salzberger, B., Hanses, F., Birkenfeld, G. et al. Schwere Infektionen. Internist 54, 925–935 (2013). https://doi.org/10.1007/s00108-012-3140-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-012-3140-4

Schlüsselwörter

Keywords

Navigation